What people are saying.

  • “I want to recommend Teresita (Tes) enthusiastically, as she embarks on the next chapter of her career: TAO DART Technical Consulting, LLC! Tes was most recently a Research Scientist in our laboratory at Bristol-Myers Squibb. She is a credentialed fetal morphologist (IRFM), with decades of experience evaluating nonclinical effects of drugs in pregnancy. She is also an expert in GLP study conduct, working as a study director at BMS for 13 years. Moreover, Tes is a consummate professional. She is very independent. Her deliverables are punctual, even when working against aggressive timelines. She is disciplined, and always calm in demeanor (even when working with individuals who are not). I endorse her expertise and professionalism without reservation.”

    — Mary Ellen McNerney, PhD

    FDA Pharmacology/Toxicology Reviewer

  • “Tes is a highly skilled and experienced fetal morphologist; you will find no one better.”

    — Josh Gamse, PhD

  • “Tes is a detail-oriented scientist with a deep background in DART study design, training, data interpretation, study monitoring, and fetal morphology. She is dedicated, thorough, well-versed in GLPs, and experienced in all facets of DART study design, execution, and interpretation.

    — Tracy Danberry, Sr Scientist

  • “Teresita (Tes) Olitan has an all encompassing skill set for DART - she is an excellent study director/monitor, capable of handling any issue that arises and exceedingly helpful in everything from study design to reporting for a multitude of DART and standard toxicology studies. She is a highly skilled fetal morphologist with decades of experience assessing fetal alterations and malformations and is an exceptional trainer. I’ve thoroughly enjoyed working with her and consider her to be professional, organized, and competent, and would thoroughly recommend her as the best resource for anything DART related.”

    Vicki Sutherland, PhD
    Program Leader, DTT
    NIEHS

  • “Tes Olitan consulted for Organon Inc over the past year as a study monitor and DART consultant. She has extensive experience in DART data interpretation and study design and was a tremendous asset in ensuring regulatory compliance with such complicated studies. Her attention to detail and experience in monitoring all types of nonclinical studies was also invaluable when study monitoring GLP and non-GLP studies at CROs. I would highly recommend Tes to assist with protocol and report review as well as nonclinical study monitoring needs.”

    Val Shultz, PhD
    Organon